financetom
Business
financetom
/
Business
/
Pagaya Technologies' Q3 Adjusted Earnings, Revenue Rise; Updates Full-Year Revenue Guidance
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Pagaya Technologies' Q3 Adjusted Earnings, Revenue Rise; Updates Full-Year Revenue Guidance
Nov 10, 2025 5:14 AM

07:49 AM EST, 11/10/2025 (MT Newswires) -- Pagaya Technologies ( PGY ) reported Q3 adjusted earnings Monday of $1.02 per diluted share, up from $0.44 a year earlier.

Analysts polled by FactSet expected $0.71.

Total revenue and other income for the quarter ended Sept. 30 was $350.2 million, compared with $257.2 million a year earlier.

Analysts surveyed by FactSet expected $338.4 million.

The company said it expects Q4 total revenue and other income in the range of $333 million to $358 million. Analysts surveyed by FactSet expect $352.4 million.

The company said it now expects full-year 2025 total revenue and other income in the range of $1.30 billion to $1.33 billion, compared with the prior outlook of $1.25 billion to $1.33 billion. Analysts surveyed by FactSet expect $1.30 billion.

Pagaya Technologies ( PGY ) shares were up more than 19% in recent Monday pre-bell activity.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Data-loss prevention company Cyberhaven hit by breach, statement says
Data-loss prevention company Cyberhaven hit by breach, statement says
Dec 27, 2024
Hackers compromised an employee of the data-protection company Cyberhaven and used the worker's access to potentially steal sensitive information from the firm's users, the company said in a statement distributed to customers and reviewed by Reuters.     The hackers pushed a compromised version of Cyberhaven's Chrome browser extension to the company's users early on Wednesday, the statement said. The company urged affected...
Novartis must face claims it paid kickbacks to promote MS drug, US appeals court rules
Novartis must face claims it paid kickbacks to promote MS drug, US appeals court rules
Dec 27, 2024
NEW YORK (Reuters) - A U.S. appeals court on Friday revived a whistleblower lawsuit accusing the Swiss drugmaker Novartis of paying illegal kickbacks to doctors to induce them to promote its blockbuster multiple sclerosis drug Gilenya. In a 3-0 decision, the 2nd U.S. Circuit Court of Appeals in Manhattan said the whistleblower Steven Camburn can try to prove that Novartis...
Vaxart Gets Increased Funding for COVID-19 Pill Vaccine Study
Vaxart Gets Increased Funding for COVID-19 Pill Vaccine Study
Dec 27, 2024
11:20 AM EST, 12/27/2024 (MT Newswires) -- Vaxart ( VXRT ) said an agreement with Advanced Technology International on a COVID-19 vaccine candidate study was amended with an increase of $4.6 million in the total estimated ceiling for funding to $460.7 million. The project agreement in June covered funding for a comparative study to evaluate the company's oral pill XBB...
Microsoft-Backed OpenAI Considers Transitioning to Conventional For-Profit Company
Microsoft-Backed OpenAI Considers Transitioning to Conventional For-Profit Company
Dec 27, 2024
11:16 AM EST, 12/27/2024 (MT Newswires) -- Microsoft ( MSFT )-backed (MSFT) OpenAI is looking at reorganizing itself to become a Delaware public benefit corporation in order to raise conventional capital while maintaining a nonprofit arm, according to an OpenAI blogpost Thursday. OpenAI currently operates as both a nonprofit and for-profit entity, supported by investments from Microsoft ( MSFT )...
Copyright 2023-2026 - www.financetom.com All Rights Reserved